{"DataElement":{"publicId":"7652917","version":"1","preferredName":"Cirrhosis Etiology Type","preferredDefinition":"The type of the cause or origin of the liver cirrhosis.","longName":"CIRR_ETIO_TYPE","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"7652795","version":"1","preferredName":"Cirrhosis Etiology","preferredDefinition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy._The cause of a disease or abnormal condition.","longName":"6385021v1.0:2512801v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"6385021","version":"1","preferredName":"Cirrhosis","preferredDefinition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","longName":"C2951","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"72EC993C-0624-31BC-E053-F662850AA897","latestVersionIndicator":"Yes","beginDate":"2018-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-08","modifiedBy":"ONEDATA","dateModified":"2018-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2512801","version":"1","preferredName":"Etiology","preferredDefinition":"The cause of a disease.","longName":"C16390","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Etiology","conceptCode":"C16390","definition":"The cause of a disease or abnormal condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8A7E81-FDBA-3170-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"COOPERM","dateModified":"2016-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008571","version":"1","preferredName":"Chronic or Associated Diseases and Exposures","preferredDefinition":"chronic diseases, as well as diseases and exposures associated with cancer.","longName":"CHR_O_ASS_DZ_AND_EXP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9B9249B-AB81-2F8D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-25","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1FA8866-6931-79B3-E053-4EBD850AFC0D","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"TITARENKOI","dateModified":"2021-05-21","changeDescription":"05/10/2021 created for SVAR NWU2015-06-03_ti","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7652915","version":"1","preferredName":"Cirrhosis Etiology Type","preferredDefinition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy._The cause of a disease or abnormal condition._Something distinguishable as an identifiable class based on common qualities.","longName":"7652915v1.0","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other (Specify)","valueDescription":"Other","ValueMeaning":{"publicId":"2559666","version":"1","preferredName":"Other","longName":"2559666","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"LISU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2023793-C46D-0C53-E053-4EBD850A7F3E","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"Wilson's Disease","valueDescription":"Hepatolenticular Degeneration","ValueMeaning":{"publicId":"3211134","version":"1","preferredName":"Hepatolenticular Degeneration","longName":"3211134","preferredDefinition":"A rare autosomal recessive inherited disorder caused by mutations in the ATP7B gene. It is characterized by copper accumulation in the tissues, particularly brain and liver. It results in liver failure, neurologic, and psychotic manifestations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatolenticular Degeneration","conceptCode":"C84756","definition":"A rare autosomal recessive inherited disorder caused by mutations in the ATP7B gene. It is characterized by copper accumulation in the tissues, particularly brain and liver. It results in liver failure, neurologic, and psychotic manifestations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-D2B2-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2023793-C482-0C53-E053-4EBD850A7F3E","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"Primary Sclerosing Cholangitis","valueDescription":"Primary Sclerosing Cholangitis","ValueMeaning":{"publicId":"3210800","version":"1","preferredName":"Primary Sclerosing Cholangitis","longName":"3210800","preferredDefinition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Sclerosing Cholangitis","conceptCode":"C4828","definition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A1CC-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2023793-C48D-0C53-E053-4EBD850A7F3E","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"Primary biliary Cirrhosis","valueDescription":"Primary Biliary Cirrhosis","ValueMeaning":{"publicId":"3210799","version":"1","preferredName":"Primary Biliary Cirrhosis","longName":"3210799","preferredDefinition":"An autoimmune inflammatory disorder characterized by destruction of the small intrahepatic bile ducts. It affects predominantly females and it may lead to cirrhosis and liver failure. Patients have antimitochondrial and antinuclear antibodies in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Biliary Cirrhosis","conceptCode":"C27167","definition":"An autoimmune inflammatory disorder characterized by destruction of the small intrahepatic bile ducts. It affects predominantly females and it may lead to cirrhosis and liver failure. Patients have antimitochondrial and antinuclear antibodies in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A1AA-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2023793-C4A2-0C53-E053-4EBD850A7F3E","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"Autoimmune Hepatitis","valueDescription":"Autoimmune Hepatitis","ValueMeaning":{"publicId":"3210889","version":"1","preferredName":"Autoimmune Hepatitis","longName":"3210889","preferredDefinition":"Hepatitis caused by autoantibodies. Drugs, infections, and toxins may trigger the production of the autoantibodies against the liver parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune Hepatitis","conceptCode":"C27029","definition":"Hepatitis caused by autoantibodies. Drugs, infections, and toxins may trigger the production of the autoantibodies against the liver parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B01E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2023793-C4AD-0C53-E053-4EBD850A7F3E","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"NASH or NAFLD","valueDescription":"Nonalcoholic Fatty Liver Disease Or Nonalcoholic Fatty Liver Disease","ValueMeaning":{"publicId":"7652916","version":"1","preferredName":"Nonalcoholic Fatty Liver Disease Or Nonalcoholic Fatty Liver Disease","longName":"7652916","preferredDefinition":"A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nonalcoholic Fatty Liver Disease","conceptCode":"C84444","definition":"A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nonalcoholic Fatty Liver Disease","conceptCode":"C84444","definition":"A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2023793-C4BC-0C53-E053-4EBD850A7F3E","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2023793-C4D5-0C53-E053-4EBD850A7F3E","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"HBV Infection","valueDescription":"Hepatitis B Infection","ValueMeaning":{"publicId":"4761116","version":"1","preferredName":"Hepatitis B Infection","longName":"4761116v1.00","preferredDefinition":"A viral infection caused by the hepatitis B virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Infection","conceptCode":"C3097","definition":"A viral infection caused by the hepatitis B virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12375748-2AE9-8D8D-E050-BB89AD430CF5","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-03-26","modifiedBy":"GDEEN","dateModified":"2023-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2023793-C4E9-0C53-E053-4EBD850A7F3E","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"HCV Infection","valueDescription":"Hepatitis C","ValueMeaning":{"publicId":"2975596","version":"1","preferredName":"Hepatitis C","longName":"2975596","preferredDefinition":"An RNA virus, causes non-A and non-B Hepatitis and liver cancer","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Infection","conceptCode":"C3098","definition":"A viral infection caused by the hepatitis C virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C084539-0F01-6AD0-E040-BB89AD43189B","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2023793-C4FE-0C53-E053-4EBD850A7F3E","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"},{"value":"Alcohol","valueDescription":"Alcohol","ValueMeaning":{"publicId":"2567315","version":"1","preferredName":"Alcohol","longName":"2567315","preferredDefinition":"A volatile liquid prepared by fermentation of certain carbohydrates. Alcohol acts as a central nervous system (CNS) depressant, a diuretic, and a disinfectant. Although the exact mechanism of CNS depression is unknown, alcohol may act by inhibiting the opening of calcium channels, mediated by the binding of the inhibitory neurotransmitter gamma-amino butyric acid (GABA) to GABA-A receptors, or through inhibitory actions at N-methyl-D-aspartate (NMDA)-type glutamate receptors. Alcohol inhibits the production of antidiuretic hormone, thereby producing diuresis that may lead to dehydration. This agent kills organisms by denaturing their proteins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcohol","conceptCode":"C2190","definition":"A volatile liquid prepared by fermentation of certain carbohydrates. Alcohol acts as a central nervous system (CNS) depressant, a diuretic, and a disinfectant. Although the exact mechanism of CNS depression is unknown, alcohol may act by inhibiting the opening of calcium channels, mediated by the binding of the inhibitory neurotransmitter gamma-amino butyric acid (GABA) to GABA-A receptors, or through inhibitory actions at N-methyl-D-aspartate (NMDA)-type glutamate receptors. Alcohol inhibits the production of antidiuretic hormone, thereby producing diuresis that may lead to dehydration. This agent kills organisms by denaturing their proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D400-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2023793-C509-0C53-E053-4EBD850A7F3E","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008571","version":"1","preferredName":"Chronic or Associated Diseases and Exposures","preferredDefinition":"chronic diseases, as well as diseases and exposures associated with cancer.","longName":"CHR_O_ASS_DZ_AND_EXP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9B9249B-AB81-2F8D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-25","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7652914","version":"1","preferredName":"Cirrhosis Etiology Type","preferredDefinition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.:The cause of a disease or abnormal condition.:Something distinguishable as an identifiable class based on common qualities.","longName":"C2951:C16390:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Etiology","conceptCode":"C16390","definition":"The cause of a disease or abnormal condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2023793-C43C-0C53-E053-4EBD850A7F3E","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"ONEDATA","dateModified":"2021-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2023793-C44D-0C53-E053-4EBD850A7F3E","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"TITARENKOI","dateModified":"2021-05-21","changeDescription":"05/10/2021 created for SVAR NWU2015-06-03_ti","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5280814","version":"1","longName":"NWU2015-06-03","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Cirrhosis etiology","type":"Preferred Question Text","description":"Cirrhosis etiology","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2023793-C516-0C53-E053-4EBD850A7F3E","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-10","modifiedBy":"TITARENKOI","dateModified":"2021-05-24","changeDescription":"05/10/2021 created for SVAR NWU2015-06-03_ti","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}